Product category:
Laboratory and scientific consultancy services
News Release from: NCE Discovery
Edited by the Laboratorytalk Editorial
Team on 27 November 2002
Finnish firm finds medicinal chemistry
expertise
Finnish biotechnology and drug development company moves its drug discovery programme with services in medicinal chemistry and synthesis
Finnish biotechnology and drug development company BioTie Therapies is working with NCE Discovery to move its drug discovery programme forward Anne Marjamaki, head of molecular pharmacology at BioTie, explained: "Our main disease focus lies in dependency disorders, inflammation and glycobiology
This article was originally published on Laboratorytalk on 13 Aug 2002 at 8.00am (UK)
Related stories
Xcellsyz appoints medicinal chemistry consultants
Xcellsyz Ltd, the London-based biotechnology company, has engaged NCE Discovery as consultants on a number of medicinal chemistry projects.
We needed the services of NCE Discovery because we don't have any medicinal chemistry or synthesis expertise ourselves." "Initially, we performed a screening programme against a particular target to provide the medicinal chemists from NCE Discovery with weak active compounds.
They used these, along with active structures they found with the help of molecular modelling and database searches, to create the basis for a focused library synthesis programme.
Our aim is to increase the potency of the most promising actives and the plan now is to try to raise this potential even more and proceed to lead optimisation." "We have an excellent working relationship with NCE Discovery and we keep in contact on a regular basis.
Above all, the good communication between us means that work is completed on schedule but there is still some flexibility, even when we need something that is not in the original contract.
We are very pleased that the project with NCE Discovery has been so successful.".
• NCE Discovery: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

